Interstitial Lung Disease
What is Interstitial Lung Disease (ILD)?
Interstitial Lung Disease (ILD) refers to a group of about >200 chronic lung disorders characterized by inflammation and scarring that make it hard for the lungs to get enough oxygen. The scarring is called pulmonary fibrosis. The symptoms and course of these diseases may vary from person to person.
No current studies. If you would like to be contacted for future research opportunities, please call us at 780-492-3741.
We do not send emails, as these are not confidential.
What is Idiopathic Pulmonary Fibrosis?
​Idiopathic Pulmonary Fibrosis (IPF) is a chronic fibrosing lung condition of unknown cause. IPF causes the tissue in the lungs to become thick and stiff, or scarred, over time resulting in shortness of breath and an unproductive cough. As the lung tissue becomes thicker, the lungs lose their ability to move oxygen into the bloodstream.
As a result, the brain and other organs do not get the oxygen they need. People who have IPF experience difficulty breathing and shortness of breath which will get worse over time. Prognosis is poor with an average survival rate of 2-3 years from the time of diagnosis.
IPF is the most common of the Interstitial Lung Diseases (ILDs), affecting about 14,000 to 15,000 Canadians.
No current studies. If you would like to be contacted for future research opportunities, please call us at 780-492-3741.
We do not send emails, as these are not confidential.